Efficacy and limitations of stereotactic radiosurgery in the treatment of glioblastoma

Neurologia Medico-Chirurgica

Volumn 52, Issue 8, 2012, Pages 548-552

  Koga, Tomoyuki ^a   Saito, Nobuhito ^a  

^a UNIVERSITY OF TOKYO HOSPITAL   (Japan)

Author keywords

Gamma knife; Glioblastoma; Stereotactic radiosurgery

Indexed keywords

BEVACIZUMAB; TEMOZOLOMIDE;

CANCER SURVIVAL; CLINICAL EFFECTIVENESS; COMPUTER ASSISTED RADIOTHERAPY; CONFERENCE PAPER; DRUG EFFICACY; GAMMA KNIFE RADIOSURGERY; GLIOBLASTOMA; HUMAN; MORBIDITY; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; RADIATION DOSE; RADIATION FIELD; RADIATION SICKNESS; RECURRENT CANCER; STEREOTACTIC RADIOSURGERY;

BRAIN NEOPLASMS; GLIOBLASTOMA; HUMANS; NEOPLASM RECURRENCE, LOCAL; OUTCOME ASSESSMENT (HEALTH CARE); RADIOSURGERY;

EID: 84865470871     PISSN: 04708105     EISSN: 13498029     Source Type: Journal    
DOI: 10.2176/nmc.52.548     Document Type: Conference Paper

References (43)

1. Barker FG 2nd, Chang SM, Gutin PH, Malec MK, McDermott MW, Prados MD, Wilson CB: Survival and functional status after resection of recurrent glioblastoma multiforme. Neurosurgery 42: 709-720, 1998
2. Biswas T, Okunieff P, Schell MC, Smudzin T, Pilcher WH, Bakos RS, Vates GE, Walter KA, Wensel A, Korones DN, Milano MT: Stereotactic radiosurgery for glioblastoma: retrospective analysis. Radiat Oncol 4: 11, 2009
3. Brandes AA, Tosoni A, Franceschi E, Sotti G, Frezza G, Amista P, Morandi L, Spagnolli F, Ermani M: Recurrence pattern after temozolomide concomitant with and adjuvant to radiotherapy in newly diagnosed patients with glioblastoma: correlation With MGMT promoter methylation status. J Clin Oncol 27: 1275-1279, 2009
4. Chamberlain MC, Barba D, Kormanik P, Shea WM: Stereotactic radiosurgery for recurrent gliomas. Cancer 74: 1342-1347, 1994
5. Chang SM, Parney IF, Huang W, Anderson FA Jr, Asher AL, Bernstein M, Lillehei KO, Brem H, Berger MS, Laws ER: Patterns of care for adults with newly diagnosed malignant glioma. JAMA 293: 557-564, 2005
6. Combs SE, Widmer V, Thilmann C, Hof H, Debus J, Schulz-Ertner D: Stereotactic radiosurgery (SRS): treatment option for recurrent glioblastoma multiforme (GBM). Cancer 104: 2168-2173, 2005
7. Dirks P, Bernstein M, Muller PJ, Tucker WS: The value of reoperation for recurrent glioblastoma. Can J Surg 36: 271-275, 1993
8. Einstein DB, Wessels B, Bangert B, Fu P, Nelson AD, Cohen M, Sagar S, Lewin J, Sloan A, Zheng Y, Williams J, Colussi V, Vinkler R, Maciunas R: Phase II trial of radiosurgery to magnetic resonance spectroscopy-defined high-risk tumor volumes in patients with glioblastoma multiforme. Int J Radiat Oncol Biol Phys Epub 2012 Mar 21
9. Endo H, Kumabe T, Jokura H, Shirane R, Tominaga T: Stereotactic radiosurgery for nodular dissemination of anaplastic ependymoma. Acta Neurochir (Wien) 146: 291-298, 2004
10. Grosu AL, Weber WA, Franz M, Stark S, Piert M, Thamm R, Gumprecht H, Schwaiger M, Molls M, Nieder C: Reirradiation of recurrent high-grade gliomas using amino acid PET (SPECT)/CT/MRI image fusion to determine gross tumor volume for stereotactic fractionated radiotherapy. Int J Radiat Oncol Biol Phys 63: 511-519, 2005
11. Gutin PH, Iwamoto FM, Beal K, Mohile NA, Karimi S, Hou BL, Lymberis S, Yamada Y, Chang J, Abrey LE: Safety and efficacy of bevacizumab with hypofractionated stereotactic irradiation for recurrent malignant gliomas. Int J Radiat Oncol Biol Phys 75: 156-163, 2009
12. Hall WA, Djalilian HR, Sperduto PW, Cho KH, Gerbi BJ, Gibbons JP, Rohr M, Clark HB: Stereotactic radiosurgery for recurrent malignant gliomas. J Clin Oncol 13: 1642-1648, 1995
13. Hau P, Baumgart U, Pfeifer K, Bock A, Jauch T, Dietrich J, Fabel K, Grauer O, Wismeth C, Klinkhammer-Schalke M, Allgauer M, Schuierer G, Koch H, Schlaier J, UlrichW, Brawanski A, Bogdahn U, Steinbrecher A: Salvage therapy in patients with glioblastoma: is there any benefit? Cancer 98: 2678-2686, 2003
14. Hsieh PC, Chandler JP, Bhangoo S, Panagiotopoulos K, Kalapurakal JA, MarymontMH, Cozzens JW, Levy RM, Salehi S: Adjuvant gamma knife stereotactic radiosurgery at the time of tumor progression potentially improves survival for patients with glioblastoma multiforme. Neurosurgery 57: 684-692, 2005
15. Kano H, Kondziolka D, Niranjan A, Flickinger JC, Lunsford LD: Stereotactic radiosurgery for pilocytic astrocytomas part 1: outcomes in adult patients. J Neurooncol 95: 211-218, 2009
16. Kano H, Niranjan A, Kondziolka D, Flickinger JC, Lunsford LD: Outcome predictors for intracranial ependymoma radiosurgery. Neurosurgery 64: 279-287, 2009
17. Kinoshita M, Izumoto S, Kagawa N, Hashimoto N, Maruno M, Yoshimine T: Long-term control of recurrent anaplastic ependymoma with extracranial metastasis: importance of multiple surgery and stereotactic radiosurgery procedures-case report. Neurol Med Chir (Tokyo) 44: 669-673, 2004
18. Koga T, Maruyama K, Igaki H, Tago M, Saito N: The value of image coregistration during stereotactic radiosurgery. Acta Neurochir (Wien) 151: 465-471, 2009
19. Koga T, Maruyama K, Tanaka M, Ino Y, Saito N, Nakagawa K, Shibahara J, Todo T: Extended field stereotactic radiosurgery for recurrent glioblastoma. Cancer Epub 2011 Dec 16
20. Koga T, Morita A, Maruyama K, Tanaka M, Ino Y, Shibahara J, Louis DN, Reifenberger G, Itami J, Hara R, Saito N, Todo T: Long-term control of disseminated pleomorphic xanthoastrocytoma with anaplastic features by means of stereotactic irradiation. Neuro Oncol 11: 446-451, 2009
21. Koga T, Shin M, Saito N: Role of gamma knife radiosurgery in neurosurgery: past and future perspectives. Neurol Med Chir (Tokyo) 50: 737-748, 2010
22. Kondziolka D, Flickinger JC, Bissonette DJ, Bozik M, Lunsford LD: Survival benefit of stereotactic radiosurgery for patients with malignant glial neoplasms. Neurosurgery 41: 776-783, 1997
23. Kong DS, Lee JI, Park K, Kim JH, Lim DH, Nam DH: Efficacy of stereotactic radiosurgery as a salvage treatment for recurrent malignant gliomas. Cancer 112: 2046-2051, 2008
24. Larson DA, Gutin PH, McDermott M, Lamborn K, Sneed PK, Wara WM, Flickinger JC, Kondziolka D, Lunsford LD, Hudgins WR, Friehs GM, Haselsberger K, Leber K, Pendl G, Chung SS, Coffey RJ, Dinapoli R, Shaw EG, Vermeulen S, Young RF, Hirato M, Inoue HK, Ohye C, Shibazaki T: Gamma knife for glioma: selection factors and survival. Int J Radiat Oncol Biol Phys 36: 1045-1053, 1996
25. Larson DA, Suplica JM, Chang SM, Lamborn KR, McDermott MW, Sneed PK, Prados MD, Wara WM, Nicholas MK, Berger MS: Permanent iodine 125 brachytherapy in patients with progressive or recurrent glioblastoma multiforme. Neuro Oncol 6: 119-126, 2004
26. Levivier M, Massager N, Wikler D, Devriendt D, Goldman S: Integration of functional imaging in radiosurgery: the example of PET scan. Prog Neurol Surg 20: 68-81, 2007
27. LevivierM, Wikier D, Goldman S, David P, Metens T, Massager N, Gerosa M, Devriendt D, Desmedt F, Simon S, Van Houtte P, Brotchi J: Integration of the metabolic data of positron emission tomography in the dosimetry planning of radiosurgery with the gamma knife: early experience with brain tumors. Technical note. J Neurosurg 93 Suppl 3: 233-238, 2000
28. Levivier M, Wikler D Jr, Massager N, David P, Devriendt D, Lorenzoni J, Pirotte B, Desmedt F, Simon S Jr, Goldman S, Van Houtte P, Brotchi J: The integration of metabolic imaging in stereotactic procedures including radiosurgery: a review. J Neurosurg 97(5 Suppl): 542-550, 2002
29. Louis DN, Ohgaki H, Wiestler OD, CaveneeWK (eds): WHO Classification of Tumours of the Central Nervous System. Lyon, IARC Press, 2007
30. Mahajan A, McCutcheon IE, Suki D, Chang EL, Hassenbusch SJ, Weinberg JS, Shiu A, Maor MH, Woo SY: Case-control study of stereotactic radiosurgery for recurrent glioblastoma multiforme. J Neurosurg 103: 210-217, 2005
31. Masciopinto JE, Levin AB, Mehta MP, Rhode BS: Stereotactic radiosurgery for glioblastoma: a final report of 31 patients. J Neurosurg 82: 530-535, 1995
32. MehtaMP, Masciopinto J, Rozental J, Levin A, Chappell R, Bastin K, Miles J, Turski P, Kubsad S, Mackie T, Kinsella T: Stereotactic radiosurgery for glioblastoma multiforme: report of a prospective study evaluating prognostic factors and analyzing longterm survival advantage. Int J Radiat Oncol Biol Phys 30: 541-549, 1994
33. Milano MT, Okunieff P, Donatello RS, Mohile NA, Sul J, Walter KA, Korones DN: Patterns and timing of recurrence after temozolomide-based chemoradiation for glioblastoma. Int J Radiat Oncol Biol Phys 78: 1147-1155, 2010
34. Park KJ, Kano H, Iyer A, Liu X, Niranjan A, Flickinger JC, Lieberman FS, Lunsford LD, Kondziolka D: Salvage gamma knife stereotactic radiosurgery followed by bevacizumab for recurrent glioblastoma multiforme: a case-control study. J Neurooncol 107: 323-333, 2012
35. Patel M, Siddiqui F, Jin JY, Mikkelsen T, Rosenblum M, Movsas B, Ryu S: Salvage reirradiation for recurrent glioblastoma with radiosurgery: radiographic response and improved survival. J Neurooncol 92: 185-191, 2009
36. Pouratian N, Crowley RW, Sherman JH, Jagannathan J, Sheehan JP: Gamma Knife radiosurgery after radiation therapy as an adjunctive treatment for glioblastoma. J Neurooncol 94: 409-418, 2009
37. Sarkaria JN, Mehta MP, Loeffler JS, Buatti JM, Chappell RJ, Levin AB, Alexander E 3rd, Friedman WA, Kinsella TJ: Radiosurgery in the initial management of malignant gliomas: survival comparison with the RTOG recursive partitioning analysis. Radiation Therapy Oncology Group. Int J Radiat Oncol Biol Phys 32: 931-941, 1995
38. Shrieve DC, Alexander E 3rd, Black PM, Wen PY, Fine HA, Kooy HM, Loeffler JS: Treatment of patients with primary glioblastoma multiforme with standard postoperative radiotherapy and radiosurgical boost: prognostic factors and long-term outcome. J Neurosurg 90: 72-77, 1999
39. Shrieve DC, Alexander E 3rd, Wen PY, Fine HA, Kooy HM, Black PM, Loeffler JS: Comparison of stereotactic radiosurgery and brachytherapy in the treatment of recurrent glioblastoma multiforme. Neurosurgery 36: 275-282, 1995
40. Souhami L, Seiferheld W, Brachman D, Podgorsak EB, Werner-Wasik M, Lustig R, Schultz CJ, SauseW, Okunieff P, Buckner J, Zamorano L, Mehta MP, Curran WJ Jr: Randomized comparison of stereotactic radiosurgery followed by conventional radiotherapy with carmustine to conventional radiotherapy with carmustine for patients with glioblastoma multiforme: report of Radiation Therapy Oncology Group 93-05 protocol. Int J Radiat Oncol Biol Phys 60: 853-860, 2004
41. Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, Belanger K, Brandes AA, Marosi C, Bogdahn U, Curschmann J, Janzer RC, Ludwin SK, Gorlia T, Allgeier A, Lacombe D, Cairncross JG, Eisenhauer E, Mirimanoff RO: Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352: 987-996, 2005
42. Vordermark D, Kolbl O, Ruprecht K, Vince GH, Bratengeier K, Flentje M: Hypofractionated stereotactic re-irradiation: treatment option in recurrent malignant glioma. BMC Cancer 5: 55, 2005
43. Wong ET, Hess KR, Gleason MJ, Jaeckle KA, Kyritsis AP, Prados MD, Levin VA, Yung WK: Outcomes and prognostic factors in recurrent glioma patients enrolled onto phase II clinical trials. J Clin Oncol 17: 2572-2578, 1999